Slow Capital’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-58,246
Closed -$878K 165
2023
Q1
$878K Buy
58,246
+23,836
+69% +$527K 0.16% 113
2022
Q4
$819K Sell
34,410
-32,870
-49% -$953K 0.18% 116
2022
Q3
$2.37M Buy
67,280
+3,035
+5% +$129K 0.51% 52
2022
Q2
$2.25M Buy
64,245
+14,131
+28% +$501K 0.55% 58
2022
Q1
$2.48M Buy
50,114
+23,076
+85% +$1.28M 0.46% 72
2021
Q4
$2.09M Buy
27,038
+12,066
+81% +$1.24M 0.36% 96
2021
Q3
$1.6M Buy
14,972
+160
+1% +$18.3K 0.29% 110
2021
Q2
$1.97M Buy
14,812
+4,135
+39% +$481K 0.37% 98
2021
Q1
$1.63M Buy
+10,677
New +$1.62M 0.35% 107
2020
Q4
Sell
-125
Closed -$9K 278
2020
Q3
$9K Buy
+125
New +$7.78K ﹤0.01% 242

Other funds holding TWST

Slow Capital's TWST Position: Q2 2023 in Review

Slow Capital sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 58,246 shares — an estimated $878K sold.

Slow Capital first reported a position in TWST in Q3 2020 and held it in 10 quarters. The position peaked at $2.48M in Q1 2022. 193 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

  • Slow Capital reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
  • Slow Capital sold 58,246 Twist Bioscience shares in Q2 2023, an estimated $878K.
  • Slow Capital first reported a position in Twist Bioscience in Q3 2020 and held it in 10 quarters.
  • Slow Capital's Twist Bioscience position peaked at $2.48M in Q1 2022.
  • 193 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Slow Capital's 13F filing for Q2 2023, filed 9 Aug 2023.